The buying and selling of stock by a company’s insider give investors a sense that the stock will rise or fall in the future. Kiniksa Pharmaceuticals International Plc shares valued at $1,697,630 were sold by Patel Sanj K on May 28 ’25. At $27.33 per share, Patel Sanj K sold 62,116 shares. The insider’s holdings dropped to 96,674 shares worth approximately $2.63 million following the completion of this transaction.
Also, Patel Sanj K sold 19,317 shares, netting a total of over 521,752 in proceeds. Following the sale of shares at $27.01 each, the insider now holds 96,674 shares.
Before that, Patel Sanj K had sold 4,837 shares from its account. In a trade valued at $130,599, the CHAIRMAN & CEO traded Kiniksa Pharmaceuticals International Plc shares for $27.00 each. Upon closing the transaction, the insider’s holdings decreased to 4,837 shares, worth approximately $2.63 million.
As published in their initiating research note from Citigroup on March 13, 2025, Kiniksa Pharmaceuticals International Plc [KNSA] has been a Buy and the price target has been revised to $40. Analysts at Jefferies started covering the stock with ‘”a Buy”‘ outlook in a report released in mid September. As of May 03, 2024, Wells Fargo has initiated its “an Overweight” rating for KNSA. Earlier on June 29, 2020, BofA Securities resumed its rating. Their recommendation was “a Buy” for KNSA stock.
Analyzing KNSA Stock Performance
During the last five days, there has been a surge of approximately 4.06%. Over the course of the year, Kiniksa Pharmaceuticals International Plc shares have jumped approximately 37.41%. Shares of the company reached a 52-week high of $28.56 on 05/05/25 and a 52-week low of $17.82 on 01/13/25.
Support And Resistance Levels for Kiniksa Pharmaceuticals International Plc (KNSA)
According to the 24-hour chart, there is a support level at 26.87, which, if violated, would cause prices to drop to 26.57. In the upper region, resistance lies at 27.69. The next price resistance is at 28.21. RSI (Relative Strength Index) is 61.56 on the 14-day chart, showing neutral technical sentiment.
